Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00219622 · ClinicalTrials.gov registry record · Phase 2
A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
NCT00219622 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 300 participants.
The verdict
NCT00219622, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
Study Summary
This an initial proof of concept, phase to study to assess the safety and efficacy of tofimilast for the chronic maintenance treatment of adults with Chronic Obstructive Pulmonary Disease
Interventions
- DRUG tofimilast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2004-05 |
| Est. Completion | 2005-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00219622
The ClinicalTrials.gov registry entry for NCT00219622 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tofimilast is the first listed.
NCT00219622 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00219622 about?
NCT00219622 is a clinical study titled "A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease". This an initial proof of concept, phase to study to assess the safety and efficacy of tofimilast for the chronic maintenance treatment of adults with Chronic Obstructive Pulmonary Disease
What is the current status of trial NCT00219622?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2004-05. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00219622?
The interventions under investigation include: tofimilast (DRUG).
Who is sponsoring clinical trial NCT00219622?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.